In this study, we found that the NE-induced IL-6 production in SSc fibroblasts is additively enhanced by treatment with ET-1, suggesting that NE:ARβ signaling and ET-1:ET receptor signaling additively enhance IL-6 production in these cells. The gene discussed is BEST1; the disease is systemic sclerosis.